Koeris Contributes Article on COVID-19 Immunity to Timmerman Report

This article originally appeared on timmermanreport.com on April 6, 2020.

By Michael Koeris

Germany, my home country, has gotten attention lately for doing some things right in its pandemic response. Diagnostic testing has been a key factor in keeping its death rate relatively low.

As a biotech entrepreneur, and with my PhD training in biomedical engineering, I want to think ahead about working on another useful idea the Germans, among others, are considering: Serology tests that look for protective antibodies against the SARS-CoV-2 virus.

To read the full article, click here.